The Class I recall includes units distributed from September 2020 to August 2021.

For Boston Scientific, the acquisition will add new left heart access platforms to its electrophysiology and structural heart portfolios.

The portable sensor, developed by specialists at the University of Notre Dame and University of Florida, targets the patient's microRNA.

Prior studies have suggested that TAVR patients could face worse outcomes if they require a permanent pacemaker. 

AFib episodes that last 5.5 hours or longer increase a patient’s risk of ischemic stroke by a significant margin. 

The findings, based on Medicare data, were presented at VIVA21 in Las Vegas.

According to a new analysis, the widespread use of remote heart failure care during the pandemic may lead to increased telemedicine use in the future.